Globus Medical Inc (NYSE: GMED) has reported earnings for its third fiscal quarter (ending September 30) of $0.38 versus $0.01 for the same period a year ago — an increase of 3700%. E.P.S. were $0.67 for the latest four quarters through September 30 versus $1.53 for the same period a year ago — a decline of -56%.
Recent Price Action
On 11/5/24, Globus Medical Inc (NYSE: GMED) stock increased 1.2%, closing at $75.58. Moreover, this advance was accompanied by unusually high trading volume at 196% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 1.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, GMED is expected to continue to be a modest Value Builder.
Globus Medical has a current Value Trend Rating of A (Highest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Globus Medical has a slightly positive Appreciation Score of 66 and a very high Power Rating of 91, producing the Highest Value Trend Rating.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment